Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate remains one of the most important tools in contemporary anaesthesia and severe discomfort management throughout the United Kingdom. As a potent artificial opioid, its role in the National Health Service (NHS) and personal surgical sectors is well-established, primarily due to its quick start of action and cardiovascular stability. This article offers a comprehensive summary of fentanyl citrate injection formulations offered in the UK, their clinical signs, regulatory landscape, and administration protocols.
What is Fentanyl Citrate?
Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was first manufactured in 1960 and rapidly became a foundation of perioperative care. In terms of effectiveness, fentanyl is roughly 50 to 100 times more powerful than morphine. Its high lipophilicity permits it to cross the blood-brain barrier rapidly, resulting in a nearly instant analgesic impact when administered intravenously.
In the UK, fentanyl citrate is predominantly used through the parenteral route (injection) for both sedative and analgesic purposes. It works mostly by binding to the mu-opioid receptors in the main nerve system, modifying the understanding of discomfort and the psychological action to it.
Clinical Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is shown for several specific scientific situations:
- Analgesic Action: Used throughout brief operative procedures and in the healing room.
- Analgesic Supplement: Used during the induction and maintenance of inhalation anaesthesia.
- Neuroleptanalgesia: Often utilized in combination with a neuroleptic (such as droperidol) to attain a state of quiescence and lowered awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
- Pre-medication: To supply sedation and analgesia before the induction of basic anaesthesia.
Available Formulations and Strengths in the UK
The UK market uses numerous formulas of fentanyl citrate, created to satisfy the varying needs of surgical and emergency situation departments. These are generally provided as clear, colourless solutions for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Common Packaging | Producer Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Load of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Load of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Pack of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU use) |
Note: While 50 mcg/ml is the basic concentration, specialised formulas for epidural or intrathecal use might in some cases be prepared by hospital drug stores under particular procedures.
Pharmacokinetics and Pharmacodynamics
Understanding how the body processes fentanyl is essential for safe administration.
- Beginning of Action: When administered intravenously, the effect begins nearly immediately, though the optimum analgesic impact might take 3 to 5 minutes.
- Duration: A single intravenous dosage of 100 micrograms generally lasts for 30 to 60 minutes.
- Metabolism: Fentanyl is mainly metabolised in the liver through the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dosage is excreted in the urine within 24 hours, primarily as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly controlled and typically carried out by anaesthetists or trained practitioners in controlled environments.
Dose Guidelines
Dosage needs to be horizontal and individualised based upon the client's age, weight, physical status, underlying pathological condition, use of other drugs, and the kind of surgery.
- Low Dose (2 mcg/kg): Useful for minor surgeries.
- Moderate Dose (2-- 20 mcg/kg): Used when surgical treatment is more invasive; requires respiratory monitoring.
- High Dose (20-- 50 mcg/kg): Used during "worry-free" major surgeries (e.g., open-heart surgical treatment) to secure the myocardium from the metabolic demands of stress.
Paths of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer treatments or in the ICU.
- Intramuscular (IM): Less common, but used for pre-medication in particular circumstances.
Regulatory Status and Safety
In the United Kingdom, Fentanyl is categorized under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is classified as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be saved in a locked controlled drug cupboard.
- Record Keeping: Every administration needs to be recorded in a Controlled Drugs Register (CDR).
- Destruction: Surplus or expired fentanyl must be denatured and witnessed by authorised personnel.
Negative Effects and Adverse Reactions
While extremely efficient, fentanyl citrate carries a threat of significant negative effects.
- Respiratory Depression: The most severe adverse effects, which can lead to breathing arrest if not kept track of.
- Bradychardia: Often handled with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation hard, needing making use of neuromuscular obstructing agents.
- Queasiness and Vomiting: Common in the postoperative duration.
- Hypotension: Although more stable than morphine, it can still happen, particularly in hypovolaemic clients.
Comparison with Other Opioids
Clinicians frequently pick fentanyl over other opioids due to its particular pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Feature | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Beginning | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Period of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Negligible | Considerable | Minimal |
| Main Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Regularly Asked Questions (FAQ)
1. Is fentanyl citrate injection the like the fentanyl patches?
No. While they contain the exact same active drug, the injection is for immediate, severe usage in surgical or emergency situation settings. Patches (transdermal delivery) are designed for chronic, long-term pain management and launch the medication gradually over 72 hours.
2. Can fentanyl citrate be utilized for kids in the UK?
Yes, it is often utilized in paediatric anaesthesia. Nevertheless, the dose should be strictly determined based on the child's weight, and they need to be monitored carefully for breathing depression.
3. What is the villain for fentanyl?
Naloxone is the particular pharmacological antagonist used to reverse the results of fentanyl, including respiratory depression. In UK healthcare facilities, naloxone should constantly be easily offered anywhere fentanyl is administered.
4. Why is it used over morphine in heart surgery?
Fentanyl is preferred in heart surgery since it does not trigger the release of histamine, which can result in vasodilation and hypotension. It supplies cardiovascular stability even at high dosages.
5. What are Medic Store GB ?
Fentanyl citrate injection should be stored below 25 ° C and protected from light. As a Schedule 2 drug, it needs to be kept in a lawfully compliant CD cabinet.
Fentanyl citrate injection solutions are important parts of the UK's medical toolkit for handling perioperative discomfort and facilitating complex surgeries. Its high effectiveness and rapid onset deal unmatched accuracy for anaesthetists, supplied that rigorous tracking and regulative standards are kept. By comprehending the different concentrations and the strict procedures surrounding its use, health care specialists guarantee that this effective medication remains both safe and reliable for patients throughout the nation.
Disclaimer: This article is for informational purposes just and does not make up medical guidance. Health care experts need to constantly describe the Summary of Product Characteristics (SmPC) and existing BNF guidelines for the most current prescribing details.
